A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.
Frequently asked questions
What sector does A Plus Biotechnology Co., Ltd. (6918) operate in?
A Plus Biotechnology Co., Ltd. belongs to the Other sector and operates in the Medical Devices industry.
What is A Plus Biotechnology Co., Ltd. (6918) current stock price?
As of the latest data, A Plus Biotechnology Co., Ltd. stock price is NT$73.00, with a previous close of NT$72.80. A Plus Biotechnology Co., Ltd. gained NT$0.20 in the last trading session, representing a 0.27% increase.
What is A Plus Biotechnology Co., Ltd. (6918) current market capitalization?
A Plus Biotechnology Co., Ltd. market cap is approximately 2.49 billion.
What is A Plus Biotechnology Co., Ltd. (6918) Earnings Per Share (EPS)?
The trailing EPS is NT$5.15.
What is A Plus Biotechnology Co., Ltd. (6918) Price-to-Earnings (P/E) ratio?
A Plus Biotechnology Co., Ltd. current P/E ratio is 14.17.
Does A Plus Biotechnology Co., Ltd. (6918) pay dividends?
Yes. A Plus Biotechnology Co., Ltd. pays annual dividends with an annualized yield of 6.85% and an estimated annual payout of NT$5.00 per share.
When is the next ex-dividend date for A Plus Biotechnology Co., Ltd. (6918)?
The next ex-dividend date is scheduled for March 27, 2027.
What is A Plus Biotechnology Co., Ltd. (6918) beta (volatility) score?
A Plus Biotechnology Co., Ltd. has a beta of 0.059, indicating lower volatility than the overall market.
